SemiLEDs’ CFO Takes Replacement

Taiwan SemiLEDs Corp has declared that, on 2 January, David Young resigned as its chief financial officer, according to a filing announced by the US Securities and Exchange Commission (SEC).

Subsequently, on 4 January, the board of directors appointed Timothy Lin to serve as interim CFO while it conducts a search for a permanent replacement. Young has agreed to provide transition assistance to the firm for a period of time.

Lin has been deputy controller since joining the firm in October 2010. Previously, he was a senior manager at Ernst & Young (Taiwan) from October 2009 to October 2010 and a manager at Deloitte & Touche (Taiwan) from June 2006 to October 2009.

Disclaimers of Warranties
1. The website does not warrant the following:
1.1 The services from the website meets your requirement;
1.2 The accuracy, completeness, or timeliness of the service;
1.3 The accuracy, reliability of conclusions drawn from using the service;
1.4 The accuracy, completeness, or timeliness, or security of any information that you download from the website
2. The services provided by the website is intended for your reference only. The website shall be not be responsible for investment decisions, damages, or other losses resulting from use of the website or the information contained therein<
Proprietary Rights
You may not reproduce, modify, create derivative works from, display, perform, publish, distribute, disseminate, broadcast or circulate to any third party, any materials contained on the services without the express prior written consent of the website or its legal owner.

Violumas aims to provide the best variety of high-performance UVA, UVB, and UVC LEDs, encapsulated with the highest quality fused silica optics. The wide selection of beam angles (30°, 60°, 90°, 120°, and 135°) allows Violu... READ MORE

J Series JB3030C White LEDs deliver high efficacy in a 301B/H compatible footprint to lighting applications that demand long lifetimes and sulfur resistance. Pro9™ versions of these LEDs deliver up to 13% higher efficacy over the standar... READ MORE